Yungjin Pharm Co Ltd Working Capital to Net Assets Ratio
Yungjin Pharm Co Ltd working capital to net assets ratio. Yungjin Pharm Co Ltd (003520) has a Working Capital to Net Assets ratio of 23.5% as of September 2025. Working capital of ₩21.13 Billion (current assets of ₩129.17 Billion minus current liabilities of ₩108.03 Billion) is measured against net assets of ₩90.02 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 003520 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Yungjin Pharm Co Ltd (2013–2024)
Working capital to net assets ratio of Yungjin Pharm Co Ltd from 2013 to 2024. This chart shows how Yungjin Pharm Co Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 23.5%, reflecting working capital of ₩21.13 Billion against net assets of ₩90.02 Billion KRW. See Yungjin Pharm Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Yungjin Pharm Co Ltd Working Capital to Net Assets Ratio by Year (2013–2024)
Yungjin Pharm Co Ltd working capital to net assets ratio by year from 2013 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Yungjin Pharm Co Ltd from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 003520 asset base.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 10.2% | ₩9.18 Billion | ₩89.80 Billion | ₩123.82 Billion | ₩114.63 Billion | ▼ -47.2 pp |
| 2023 | 57.5% | ₩51.51 Billion | ₩89.63 Billion | ₩126.56 Billion | ₩75.06 Billion | ▼ -1.0 pp |
| 2022 | 58.5% | ₩52.56 Billion | ₩89.87 Billion | ₩102.19 Billion | ₩49.63 Billion | ▲ +19.1 pp |
| 2021 | 39.4% | ₩41.36 Billion | ₩104.89 Billion | ₩89.69 Billion | ₩48.33 Billion | ▼ -20.5 pp |
| 2020 | 59.9% | ₩68.53 Billion | ₩114.43 Billion | ₩98.67 Billion | ₩30.14 Billion | ▼ -1.9 pp |
| 2019 | 61.8% | ₩71.54 Billion | ₩115.75 Billion | ₩111.33 Billion | ₩39.79 Billion | ▼ -2.3 pp |
| 2018 | 64.1% | ₩71.58 Billion | ₩111.61 Billion | ₩109.68 Billion | ₩38.10 Billion | ▲ +0.2 pp |
| 2017 | 64.0% | ₩76.55 Billion | ₩119.65 Billion | ₩114.02 Billion | ₩37.47 Billion | ▲ +8.7 pp |
| 2016 | 55.2% | ₩58.65 Billion | ₩106.17 Billion | ₩101.56 Billion | ₩42.92 Billion | ▲ +3.9 pp |
| 2015 | 51.4% | ₩51.58 Billion | ₩100.42 Billion | ₩93.80 Billion | ₩42.22 Billion | ▲ +12.2 pp |
| 2014 | 39.1% | ₩39.45 Billion | ₩100.79 Billion | ₩82.40 Billion | ₩42.95 Billion | ▼ -4.0 pp |
| 2013 | 43.1% | ₩44.16 Billion | ₩102.45 Billion | ₩83.56 Billion | ₩39.40 Billion | — |